Insider filing · DXCM
Nicholas Augustinos
Director
profile →
DexCom, Inc.
DXCM · Healthcare · 52 filings in 24 months
ticker →
Nicholas Augustinos sold $518K of DexCom (DXCM)
Executed Jun 13 2025, disclosed Jun 17 2025, 4 days later.
Value, as filed
$518K
6,290 sh across 2 lots
Executed
Jun 13 2025
the trade date, as filed
Disclosed
Jun 17 2025
4 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
NANicholas Augustinos (Director) filed 1 Form 4 report in the past 24 months (0 purchases, 1 sale), most often in DexCom, Inc. (DXCM). The largest single filing was $518K of DXCM (6,290 sh across 2 lots, as filed), executed Jun 13 2025.
The name
DXCMHealthcare · DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) sy…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→